-
EP2540296
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2540296
| EP2540296 - Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.01.2015 Database last updated on 30.07.2024 | Most recent event Tooltip | 09.01.2015 | Application deemed to be withdrawn | published on 11.02.2015 [2015/07] | Applicant(s) | For all designated states Xenon Pharmaceuticals Inc. 3650 Gilmore Way Burnaby, BC V5G 4W8 / CA | [2013/01] | Inventor(s) | 01 /
Fu, Jian-Min 3170 Quintette Crescent Coquitlam, BC V3E 3B6 / CA | 02 /
Hou, Duanjie Nr. 46-7088 17th Avenue Burnaby BC V3N 1K5 / CA | 03 /
Rajender, Kamboj 5809 Sperling Avenue Burnaby BC V5E 2T6 / CA | 04 /
Vishnumurthy, Kodumuru 13 Jutith Lane Waltham MA 02452 / US | 05 /
Prokovskaia, Natalia 100-845 Mcbride Blvd New Westminster BC V3L 2C2 / CA | 06 /
Raina, Vandna PH3, 2763 Chandlery Place Vancouver BC V5S 4V4 / CA | 07 /
Sun, Shaoyi Nr. 5-1200 Brunette Avenue Coquitlam BC V3K 1G3 / CA | 08 /
Sviridov, Serguei 1904-5885 Olive Avenue Burnaby BC V5H 4N8 / CA | 09 /
Zhang, Zaihui 4038 MacDonald Street Vancouver BC V6L 2N9 / CA | [2013/02] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [N/P] |
| Former [2013/01] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Leopoldstrasse 4 80802 München / DE | Application number, filing date | 12005821.9 | 05.06.2006 | [2013/01] | Priority number, date | US20050687133P | 03.06.2005 Original published format: US 687133 P | [2013/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2540296 | Date: | 02.01.2013 | Language: | EN | [2013/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 05.12.2012 | Classification | IPC: | A61K31/426, A61K31/427, A61K31/4439, A61P3/00, A61P9/12, A61P17/06, A61P17/10, A61P19/06, C07D277/82, C07D417/12 | [2013/01] | CPC: |
A61K31/426 (EP,US);
C07D277/587 (US);
A61K31/427 (EP,US);
A61K31/4439 (EP,US);
A61K31/5377 (US);
A61K31/616 (US);
A61K38/26 (US);
A61K38/28 (US);
A61K45/06 (US);
A61P1/16 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P17/08 (EP);
A61P17/10 (EP);
A61P19/06 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07D277/56 (EP,US);
C07D417/06 (US);
C07D417/12 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2013/01] | Title | German: | Arminothiazolderivate als menschliche Stearoyl-Coa-Desaturase-Hemmer | [2013/01] | English: | Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors | [2013/01] | French: | Dérivés d'arminothiazole utilisés comme inhibiteurs de la stéaroyl-coa désaturase humaine | [2013/01] | Examination procedure | 01.07.2013 | Examination requested [2013/33] | 18.10.2013 | Amendment by applicant (claims and/or description) | 29.04.2014 | Despatch of a communication from the examining division (Time limit: M04) | 10.09.2014 | Application deemed to be withdrawn, date of legal effect [2015/07] | 07.10.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/07] | Parent application(s) Tooltip | EP06784578.4 / EP2029138 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060784578) is 13.08.2010 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 18.10.2013 | Request for further processing filed | 18.10.2013 | Full payment received (date of receipt of payment) Request granted | 04.11.2013 | Decision despatched | Fees paid | Renewal fee | 10.08.2012 | Renewal fee patent year 03 | 10.08.2012 | Renewal fee patent year 04 | 10.08.2012 | Renewal fee patent year 05 | 10.08.2012 | Renewal fee patent year 06 | 10.08.2012 | Renewal fee patent year 07 | 27.06.2013 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.06.2014 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]WO2005011655 (XENON PHARMACEUTICALS INC [CA], et al) [AD] 1-15* Page 144, lines 16-17,; page 1, line 3 - line 8 *; | [X] - WITYAK, JOHN ET AL, "Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS , 13(22), 4007-4010 CODEN: BMCLE8; ISSN: 0960-894X, (2003), XP002402709 [X] 7,13,14 * the whole document * DOI: http://dx.doi.org/10.1016/j.bmcl.2003.08.054 | [X] - OHKUBO, MITSURU ET AL, "Studies on cerebral protective agents. VIII. Synthesis of 2-aminothiazoles and 2-thiazolecarboxamides with anti-anoxic activity", CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1995:902192, URL: STN, XP002402712 [X] 7,13,14 * the whole document * | [X] - SINGH, S. N. ET AL, "New local anesthetics", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1972:564589, URL: STN, XP002402713 [X] 7,13,14 * the whole document * | by applicant | WO0162954 | WO0226944 | WO2005011657 | WO2005011656 | WO2005011655 | WO2005011654 | WO2005011653 | WO2006014168 | WO2006034338 | WO2006034446 | WO2006034441 | WO2006034440 | WO2006034341 | WO2006034315 | WO2006034312 | WO2006034279 | - JEFFCOAT, R. ET AL., EUR. J. BIOCHEM., (1979), vol. 101, no. 2, pages 439 - 445 | - DE ANTUENO, R. ET AL., LIPIDS, (1993), vol. 28, no. 4, pages 285 - 290 | - ATTIE, A.D. ET AL., "Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia", J. LIPID RES., (2002), vol. 43, no. 11, pages 1899 - 907 | - COHEN, P. ET AL., "Role for stearoyl-CoA desaturase-1 in leptin mediated weight loss", SCIENCE, (2002), vol. 297, no. 5579, pages 240 - 3 | - NTAMBI, J. M. ET AL., "Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity", PROC. NATL. ACAD. SCL U.S.A., (2002), vol. 99, no. 7, pages 11482 - 6 | - BUNDGARD, H., Design of Prodrugs, ELSEVIER, (1985), pages 7 - 9,21-24 | - HIGUCHI, T. ET AL., Pro-drugs as Novel Delivery Systems, vol. 14 | - GHIBAUDI, L. ET AL., OBES. RES., (2002), vol. 10, pages 956 - 963 | - GRUNDY, S., CARDIOL. REV., (2006), vol. 13, no. 6, pages 322 - 327 | - SHANKLIN J.; SUMMERVILLE C., PROC. NATT. ACAD. SCI. USA, (1991), vol. 88, pages 2510 - 2514 | - REMINGTON'S PHARMACEUTICAL SCIENCES, MACK PUB. CO. | - PATEL MONA, EXPERT OPIN. INVESTIG. DRUGS, vol. 12, no. A, pages 623 - 33 | - SHANKLIN J.; SUMMERVILLE C., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, pages 2510 - 2514 |